The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition - Guttman‐Yassky - 2019 - Experimental Dermatology - Wiley Online Library
PDE4 inhibitors in COPD—a more selective approach to treatment - Respiratory Medicine
Phosphodiesterase-4 (PDE4) inhibitors have the potential to suppress... | Download Scientific Diagram
Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis - ScienceDirect
Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook | Semantic Scholar
Schematic representation of how Phosphodiesterase 4 (PDE4) inhibitors,... | Download Scientific Diagram
The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+ lymphocyte proliferation - Kim - 2021 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
Inhibition of PDE4 by apremilast attenuates skin fibrosis through directly suppressing activation of M1 and T cells | Acta Pharmacologica Sinica
FCPR03 is a Selective Phosphodiesterase 4 (PDE4) Inhibitor - Immune System Research
Phosphodiesterase 4 inhibitors - Journal of the American Academy of Dermatology
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders - ScienceDirect
Phosphodiesterase inhibitors - Knowledge @ AMBOSS
Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases | Pharmacology
Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–drug Conjugate: Molecular Therapy
IJMS | Free Full-Text | PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue | HTML
DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling - ScienceDirect
Phosphodiesterase Inhibitors: What Are They, How Do They Work, What Are They Used For, and More | Osmosis
Rolipram is a Selective Phosphodiesterases PDE4 Inhibitor - Immune System Research
Reducing Neuroinflammation in Psychiatric Disorders: Novel Target of Phosphodiesterase 4 (PDE4) and Developing of the PDE4 Inhibitors | IntechOpen
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases | Semantic Scholar
Action of PDE4 inhibitors can prolong or enhance effects of cAMP and... | Download Scientific Diagram
Treating brain tumors with PDE4 inhibitors: Trends in Pharmacological Sciences
RCSB PDB - 5K1I: PDE4 crystal structure in complex with small molecule inhibitor
